Stefanie Lanzinger Selected Research

Stefanie Lanzinger Research Topics

Disease

12	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 01/2018
10	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2017
7	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 12/2018
5	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 01/2021
4	Hypertension (High Blood Pressure) 01/2022 - 01/2016
3	Coma (Comas) 01/2023 - 01/2021
3	Dyslipidemias (Dyslipidemia) 01/2022 - 11/2018
3	Body Weight (Weight, Body) 12/2021 - 01/2018
3	Overweight 02/2020 - 01/2017
2	Stroke (Strokes) 01/2023 - 01/2023
2	Heart Failure 01/2023 - 01/2023
2	Myocardial Infarction 01/2023 - 01/2023
2	Chronic Renal Insufficiency 01/2023 - 01/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2024
1	Albuminuria 01/2023
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2023
1	Kidney Diseases (Kidney Disease) 01/2023
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Bone Fractures (Bone Fracture) 01/2023
1	Hyperglycemia 11/2022
1	Ketosis 11/2022
1	Hashimoto Disease (Thyroiditis, Hashimoto) 07/2021
1	Feeding and Eating Disorders (Eating Disorder) 07/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 07/2021
1	Mental Disorders (Mental Disorder) 07/2021
1	Schizophrenia (Dementia Praecox) 07/2021
1	Thyroid Diseases (Thyroid Disease) 07/2021
1	COVID-19 01/2021
1	Vascular Diseases (Vascular Disease) 02/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Hyperkalemia 01/2019
1	Hypersensitivity (Allergy) 01/2017
1	Respiratory Sounds (Crackle) 01/2017
1	Asthma (Bronchial Asthma) 01/2017
1	Insulin Resistance 01/2016
1	Hypertriglyceridemia 01/2016
1	Diabetes Mellitus 10/2014

Drug/Important Bio-Agent (IBA)

9	Insulin (Novolin)FDA Link 01/2023 - 01/2018
9	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2016
3	SodiumIBA 01/2023 - 01/2022
3	Hemoglobins (Hemoglobin)IBA 11/2022 - 01/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 02/2020
2	empagliflozinIBA 01/2023 - 01/2023
2	Blood Glucose (Blood Sugar)IBA 11/2022 - 01/2019
2	Short-Acting InsulinIBA 11/2022 - 12/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 11/2022 - 01/2019
2	LipidsIBA 01/2022 - 01/2017
2	Particulate MatterIBA 01/2022 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 04/2024
1	Antirheumatic Agents (DMARD)IBA 04/2024
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	finerenoneIBA 01/2023
1	Mineralocorticoid Receptor AntagonistsIBA 01/2023
1	Insulin Lispro (Humalog)FDA Link 11/2022
1	AntibodiesIBA 07/2021
1	Iodide Peroxidase (Deiodinase)IBA 07/2021
1	Thyroglobulin FDA Link 07/2021
1	Thyroid HormonesIBA 07/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2021
1	Sodium-Glucose Transport ProteinsIBA 01/2021
1	AngiotensinsIBA 01/2021
1	AldosteroneIBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	ReninIBA 01/2021
1	InsulinsIBA 01/2021
1	Protamines (Protamine Sulfate)FDA Link 01/2021
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 07/2020
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 12/2018
1	OzoneIBA 01/2018
1	Disinfectants (Biocides)IBA 01/2017
1	Nicotine FDA Link 01/2017
1	LDL CholesterolIBA 01/2016
1	HDL LipoproteinsIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	Nitroglycerin (Dynamite)FDA LinkGeneric 10/2014

Therapy/Procedure

4	Therapeutics 04/2024 - 02/2020
4	Glycemic Control 01/2023 - 01/2021
2	Length of Stay 01/2021 - 01/2021
1	Surgical Amputation (Amputations) 01/2023